In Vitro Activities of Novel Azole Compounds ATTAF-1 and ATTAF-2 against Fluconazole-Susceptible and -Resistant Isolates of Candida Species

Antimicrob Agents Chemother. 2016 Dec 27;61(1):e01106-16. doi: 10.1128/AAC.01106-16. Print 2017 Jan.

Abstract

The in vitro activities of two novel azole compounds (aryl-1,2,4-triazol-3-ylthio analogues of fluconazole [ATTAFs]) and five comparator antifungal agents against 52 clinical Candida isolates from 5 different species were determined. The novel azole compounds had the lowest geometric mean MICs, followed by fluconazole. Moreover, combinations of these compounds with fluconazole exhibited synergistic effects against fluconazole-susceptible (22 of 23 isolates), fluconazole-susceptible dose-dependent (10 of 13 isolates), and fluconazole-resistant (1 of 16 isolates) Candida isolates.

Keywords: Candida species; In vitro susceptibility; triazole derivatives.

MeSH terms

  • Antifungal Agents / pharmacology*
  • Azoles / pharmacology*
  • Candida / drug effects
  • Drug Resistance, Fungal / genetics
  • Fluconazole / pharmacology*
  • Microbial Sensitivity Tests
  • Triazoles / pharmacology

Substances

  • Antifungal Agents
  • Azoles
  • Triazoles
  • Fluconazole